10-K: Corteva, Inc. and EIDP, Inc. Release 2023 Annual Results in Form 10-K Filing

Corteva, Inc. and its subsidiary EIDP, Inc. have released their combined 2023 annual results, showing a slight decrease in net sales but an increase in operating EBITDA.

Summary

• Corteva, Inc. reported a 1% decrease in net sales, totaling $17.226 billion for the year ended December 31, 2023, compared to $17.455 billion in 2022.
• The decrease in net sales was primarily due to a 10% decrease in volume and a 1% unfavorable impact from currency, partially offset by a 7% price increase and a 3% favorable portfolio and other impact.
• Cost of goods sold decreased to $9.920 billion, down from $10.436 billion in 2022, driven by lower volumes, cost and productivity actions, and a decrease in royalty expense, partially offset by higher input costs.
• Restructuring and asset-related charges decreased to $336 million, primarily including asset-related charges, non-cash impairment charges, and contract termination charges.
• Income from continuing operations after income taxes was $941 million, compared to $1.216 billion in 2022.
• Operating EBITDA improved to $3.381 billion, up from $3.224 billion in 2022, driven by price execution and productivity actions, partially offset by lower volumes and cost and currency headwinds.
• The company returned approximately $1.2 billion to shareholders through share repurchases and common stock dividends.
• The company's Board of Directors approved a 6.7% increase in the quarterly common stock dividend from $0.15 to $0.16 per share.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with both positive and negative aspects. While operating EBITDA improved and the company is returning capital to shareholders, there are concerns about declining sales, higher input costs, and restructuring charges. The outlook for 2024 is positive, but the company faces significant risks and uncertainties.

Positives

• Operating EBITDA increased year-over-year, indicating improved profitability.
• The company successfully executed price increases, demonstrating pricing power.
• The company is actively returning capital to shareholders through buybacks and dividends.
• The acquisitions of Stoller and Symborg are expected to enhance the crop protection business.
• The company is implementing cost-saving measures through restructuring programs.

Negatives

• Net sales decreased by 1% year-over-year, primarily due to lower volumes.
• Income from continuing operations after income taxes decreased compared to the previous year.
• The company experienced unfavorable currency impacts, particularly from the Turkish Lira, Canadian Dollar and Chinese Renminbi.
• The company incurred significant restructuring and asset-related charges.
• The company experienced higher input costs, which are primarily macro-economic driven.

Risks

• The company faces risks related to regulatory approvals, product development, and public acceptance of biotechnology.
• The company is exposed to environmental liabilities and litigation, including those related to PFAS.
• The company is subject to risks from climate change, unpredictable weather, and geopolitical conflicts.
• The company faces competition from other agricultural input providers.
• The company is dependent on third parties for raw materials, licenses, and commercialization.

Future Outlook

The company expects net sales to be in the range of $17.4 billion and $17.7 billion and operating EBITDA to be in the range of $3.5 billion and $3.7 billion for 2024. The company also expects operating earnings per share to be in the range of $2.70 and $2.90 per share and free cash flow to be in the range of $1.5 billion and $2.0 billion.

Management Comments

• The company continues to believe the following priorities will create significant value for its customers and shareholders over the mid-term: accelerate performance and growth through a value creation network, increased investment in our industry-leading innovation pipeline, and deploy capital with discipline.
• The global outlook for agriculture remains constructive overall in 2024. There was record-setting demand for grain, oilseeds and biofuels in 2023 and we expect that to continue to grow in 2024. On-farm demand remains steady and overall strong.

Industry Context

The document highlights the competitive nature of the agricultural input industry, with Corteva competing against major players like BASF, Bayer, FMC, and Syngenta. The company is focused on innovation and technology to maintain its competitive edge. The document also notes the impact of global economic and geopolitical factors on the industry, including the Russia-Ukraine conflict and potential trade tensions.

Comparison to Industry Standards

• Corteva's performance is compared to the S&P 500 Stock Index and the S&P 500 Chemicals Index, showing a cumulative total return of $205 compared to $188 and $151, respectively, since June 3, 2019.
• The company's focus on new product development and technology adoption aligns with industry trends towards precision agriculture and sustainable solutions.
• The company's restructuring efforts and cost-saving initiatives are consistent with industry-wide efforts to improve efficiency and profitability.
• The company's acquisitions of Stoller and Symborg reflect a growing trend in the agricultural industry towards biological solutions.

Legal Proceedings

• The company is involved in various legal proceedings, including product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters.
• The company is facing a lawsuit from the FTC and several state attorneys general alleging anticompetitive conduct.
• The company is involved in litigation related to chlorpyrifos exposure, the active ingredient in Lorsban.
• The company is involved in disputes with Inari Agriculture, Inc. and Bayer CropScience LLP and Monsanto Company regarding intellectual property.
• The company is involved in multiple natural resource damage lawsuits across the United States filed by municipalities and alleging PFOA contamination, as well as, lawsuits by four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours.

Related Party Transactions

• EIDP has a related party revolving loan from Corteva, Inc., with a maturity date in 2024. The company repaid the outstanding related party revolving loan balance during the fourth quarter of 2023.
• EIDP and Corteva, including certain consolidated subsidiaries, are party to a Master In-House Banking Agreement, which established banking arrangements to facilitate the management of the cash and liquidity needs of the Participating Companies.

Stakeholder Impact

• Shareholders will benefit from share repurchases and increased dividends.
• Employees may be affected by restructuring and workforce reductions.
• Customers will benefit from new and improved products and services.
• Suppliers may be affected by changes in the company's supply chain.
• Creditors may be affected by changes in the company's debt levels.

Next Steps

• The company will continue to focus on accelerating performance and growth through a value creation network.
• The company will increase investment in its industry-leading innovation pipeline.
• The company will deploy capital with discipline by balancing investment, growth, M&A opportunities and returning cash to shareholders.

Key Dates

Keywords

Corteva, EIDP, agriculture, seed, crop protection, financial results, operating EBITDA, restructuring, acquisitions, share repurchase, dividends, biologicals, intellectual property, sustainability